Determination of perindopril erbumine by oxidative coupling reaction using 2, 6-dichloroquinone-4-chlorimide
DOI:
https://doi.org/10.1590/s2175-97902022e20012%20Keywords:
Spectrophotometry, Perindopril erbumine, Gibb’s reagent (DCQC), FormulationAbstract
Perindopril erbumine (Perindopril tert-butylamine salt) is a potent angiotensin-converting enzyme (ACE) inhibitor. It is used to treat the patients with hypertension and heart failure problems. A sensitive, inexpensive and precise analytical technique has been developed for the estimation of perindopril in bulk and formulations. The procedure involves the development of colour by forming an oxidative coupling reaction between drug (PPE) and reagent such as 2, 6-dichloroquinone-4-chlorimide (DCQC). The formed colored species were measured at (max=520 nm. The developed method showed linearity within the concentration limits of 25-75 μg mL-1. The linear correlation coefficient (r) and molar absorptivity were found to be 0.9999 and 3.285 x 103 mol-1cm-1. % Recovery ± SD values were in the range of 99.69 - 100.51 (+ 0.42 - ( 0.41) (n=3) which indicates the accuracy of the developed method. The interference of other excipients that are commonly present in formulations is found to be negligible. Precision and accuracy of the proposed method were confirmed by student t-test and F-tests at 95% confidence limits with (n-1) degrees of freedom. The validity parameters of proposed method were calculated by ICH guidelines.
Downloads
References
British pharmacopoeia: British pharmacopeial commission office, vol I & vol II, London, UK.; 2009. p. 4612.
Chaudhary AB, Patel RK, Chaudhary SA. Determination of losartan potassium and perindopril erbumine in tablet formulations by reversed-phase HPLC. Int J Chem Tech Res. 2010;2(2):1141-1146.
Dugga HHT, Peraman R, Nayakanti, D. Stability indicating RP-HPLC method for the quantitative analysis of perindopril erbumine in tablet dosage form. J Chromatogr Sci. 2014;52(4): 315-320.
Deepak SJ, Subbaiah G, Sanyal M, Umesh CP, Shrivastav P. First LC-MS/MS electrospray ionization validated method for the quantification of perindopril and its metabolite perindopril at in human plasma and its application to bioequivalence study. J Chromatogr B. 2006;837(1-2):92-100.
El-Gizawy SM, Abdelmageed OH, Derayea SM, Omar M A, Abdel-Megied A M, et al. Chiral separation of perindopril erbumine enantiomers using high performance liquid chromatography and capillary electrophoresis. Anal Meth. 2014;6(3):825-830
Fael H, Sakur AA. Novel spectrofluorimetric method for the determination of perindopril erbumine based on fluorescence quenching of rhodamine B. J Fluoresc. 2015a;25(6):1577-1584.
Fael H, Sakur AA. Novel spectrofluorimetric method for the determination of perindopril erbumine based on charge transfer reaction with 7-hydroxycoumarin. J Fluoresc. 2015b;25(4):811-818.
Gizawy SM., Bebawy LI, Abdelmageed OH, Omar MA, Deryea SM, Abdel-Megied AM, et al. High performance liquid chromatography, TLC-densitometry, and first-derivative spectrophotometry for simultaneous determination of amlodipine and perindopril in bulk powder and its tablets. J Liq Chromatogr Relat Technol. 2013; 36(10):1323-1339.
ICH Harmonized Tripartite Guideline. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Text and Methodology on Validation of Analytical Procedures. 2005; Q2: (R1).
Joseph PR, Alfonso R. Remington’s the science and practice of pharmacy, Lippincott Williams & Wilkins publisher, 20th ed., Baltimore, Maryland, USA; 2000; p. 1281
Joseph J, Philip B. Method development and validation for simultaneous estimation of perindopril erbumine and indapamide by RP-HPLC in pharmaceutical dosage forms. J Pharm Pharm Sci. 2011;3(4):288-293.
Kale SS, Bakal RL, Chandewar AV,Sakhare RS, et al. Two wavelength method for estimation of indapamide and perindopril erbumine in combined tablet dosage form. Res J Pharm Technol. 2011;4(4):545-548.
Montvale N.J. P.D.R.: ‘Physician’s desk reference’, 54th ed., medical economics company publisher, U.S: 2000; p. 3057
Mastannamma SK, Tejaswini IS, Reehana SK, Saidulu P. Stability indicating validated RP-HPLC method for simultaneous determination of perindopril erbumine and amlodipine besylate in bulk and pharmaceutical dosage forms. Int J Pharm Sci Rev Res. 2016;41(2):65-71.
Maurer H H, Kraemer T, Arlt JW, et al. Screening for the detection of angiotensin-converting enzyme inhibitors, their metabolites, and AT II receptor antagonists. Ther Drug Monit. 1998;20(6):706-713.
Massart DL Vandeginste BGM, Doming SN, Michotte Y, Kaufman L. Chemo metrics, A text Book, Amsterdam: Elsevier, 1988; 293: p 80.
Nayak SP, Pillai S. Simultaneous estimation of amlodipine besylate and perindopril erbumine by UV spectrophotometric method. Res J Pharm Technol . 2011;4(5):735-738.
Nirogi RV, Kandikere VN, Shukla M, Mudigonda K, Maurya S, Komarneni P, et al. High-throughput quantification of perindopril in human plasma by liquid chromatography/tandem mass spectrometry: application to a bioequivalence study. Rapid Commun Mass Spectrom. 2006;20(12):1864-1870.
Pattan SR, Patni AC, Mali RA, Patni CJ, Godge RK, Bhawar HS, Marathe RP, et al. Analytical method development and validation of perindopril erbumine and amlodipine besylate in bulk and tablet dosage form by HPLC. Indian Drugs. 2013;50(5):32-35.
Patel AI, Oza CK, Prajapati JP, Vyas AJ, Mehta P, et al. RP-HPLC method for the determination of losartan potassium and perindopril erbumine in combined tablet dosage form. Int J Pharm Biol Sci. 2011;2(1):709-715.
Prajapati J, Patel A, Patel MB, Prajapati N, Prajapati R. Analytical method development and validation of amlodipine besylate and perindopril erbumine in combine dosage form by RP-HPLC. Int J Pharm Tech Res. 2011;3(2):801-808.
Prameela Rani A, Nagalakshmi C, Bhawani S, Chandra Bala S. Determination of perindopril erbumine in tablets by spectrophotometry. Jordan J Chem. 2012;7(4):413-426.
Prameela Rani A, Bala Sekaran CA. Validated RP-HPLC method for the determination of perindopril erbumine in pharmaceutical formulations. Int J PharmTech Res. 2009;1(3):575-578.
Rahman N, Rahman H, Khatoon A. Development of spectrophotometric method for the determination of perindopril erbumine in pharmaceutical formulations using 2, 4 dinitrofluorobenzene. J Chilean Chem Soc. 2012;57(2):827-831.
Rahman N, Rahman H. Quantitative analysis of perindopril erbumine in pharmaceutical preparations by spectrophotometry via ternary complex formation with Zn(II) and eosin and charge transfer complexation with iodine. Spectroscopy. 2011;25:123-136.
Rahman N, Rahman H, Haque SM. Kinetic spectrophotometric method for the determination of perindopril erbumine in pure and commercial dosage forms. Arabian J Chem. 2017;10(Supl 1):S831-S838.
Rahman N, Anwar N, Kashif M. Optimized and validated initial-rate method for the determination of perindopril erbumine in tablets. Chem Pharm Bull. 2006;54(1):33-36.
Sastry CSP, Sastry BS, Venkateswara rao J, Rama Krishna R. Spectrophotometric methods for the determination of tolnaftate. Talanta, 1993; 40(4): 571-576
Singh M, Kaskhedikar SG, Singhvi G, Soni L. HPLC estimation of perindopril erbumine in tablet dosage form. Asian J Chem. 2011;23(9):3909-3911.
Sweetman SC. In Martindale: The complete drug reference. 36th ed., Vol II, London, Pharmaceutical Press; 2009. p.928
Sridevi N, Jahnavi G, Sekaran CB, Spectrophotometric analysis of perindopril erbumine in bulk and tablets using bromophenol blue. Der Pharmacia Lettre. 2012;4(1):159-169.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
